Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2019 Using the 4-S Framework to Guide Conversations With Patients About CRISPR Lisa S. Lehmann, MD, PhD, MSc Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences. AMA J Ethics. 2019;21(12):E1029-1035. doi: 10.1001/amajethics.2019.1029. Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036. Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361. Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376. Case and Commentary May 2022 ¿Cómo deberían responder los médicos al interés de los pacientes sobre suplementos dietético para tratar enfermedades crónicas graves? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES AMA J Ethics. 2022;E361-367. doi: 10.1001/amajethics.2022.361. Case and Commentary Mar 2023 How Should Clinicians and Researchers in Government Respond to Threats to Their Offices? Daphne Mlachila, MD, MPH During the COVID-19 pandemic, clinician policy makers have faced unprecedented challenges to their roles in governance. AMA J Ethics. 2023;25(3):E172-178. doi: 10.1001/amajethics.2023.172. Case and Commentary Sep 2007 Assisted Reproduction and Primum Non Nocere Marta Kolthoff, MD Virtual Mentor. 2007;9(9):605-610. doi: 10.1001/virtualmentor.2007.9.9.ccas2-0709. Case and Commentary Jun 2007 Sex Selection for Nonmedical Reasons Louise P. King, MD, JD Virtual Mentor. 2007;9(6):418-422. doi: 10.1001/virtualmentor.2007.9.6.ccas3-0706. Case and Commentary Nov 2005 Controlling Diabetes Robert P. Hoffman, MD Virtual Mentor. 2005;7(11):723-726. doi: 10.1001/virtualmentor.2005.7.11.ccas1-0511. Case and Commentary May 2002 Drug Marketing and Patient Consent Erica Ozanne Linden, JD, MPH Virtual Mentor. 2002;4(5):136-137. doi: 10.1001/virtualmentor.2002.4.5.hlaw1-0205. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Case and Commentary Dec 2019 Using the 4-S Framework to Guide Conversations With Patients About CRISPR Lisa S. Lehmann, MD, PhD, MSc Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences. AMA J Ethics. 2019;21(12):E1029-1035. doi: 10.1001/amajethics.2019.1029.
Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036.
Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361.
Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376.
Case and Commentary May 2022 ¿Cómo deberían responder los médicos al interés de los pacientes sobre suplementos dietético para tratar enfermedades crónicas graves? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES AMA J Ethics. 2022;E361-367. doi: 10.1001/amajethics.2022.361.
Case and Commentary Mar 2023 How Should Clinicians and Researchers in Government Respond to Threats to Their Offices? Daphne Mlachila, MD, MPH During the COVID-19 pandemic, clinician policy makers have faced unprecedented challenges to their roles in governance. AMA J Ethics. 2023;25(3):E172-178. doi: 10.1001/amajethics.2023.172.
Case and Commentary Sep 2007 Assisted Reproduction and Primum Non Nocere Marta Kolthoff, MD Virtual Mentor. 2007;9(9):605-610. doi: 10.1001/virtualmentor.2007.9.9.ccas2-0709.
Case and Commentary Jun 2007 Sex Selection for Nonmedical Reasons Louise P. King, MD, JD Virtual Mentor. 2007;9(6):418-422. doi: 10.1001/virtualmentor.2007.9.6.ccas3-0706.
Case and Commentary Nov 2005 Controlling Diabetes Robert P. Hoffman, MD Virtual Mentor. 2005;7(11):723-726. doi: 10.1001/virtualmentor.2005.7.11.ccas1-0511.
Case and Commentary May 2002 Drug Marketing and Patient Consent Erica Ozanne Linden, JD, MPH Virtual Mentor. 2002;4(5):136-137. doi: 10.1001/virtualmentor.2002.4.5.hlaw1-0205.